Used primarily in research settings for studying neuroactive compounds, Bongardol exhibits properties that make it relevant in the exploration of central nervous system depressants. It has been investigated for its potential sedative and anxiolytic effects, particularly in preclinical models. Due to its structural characteristics, it may interact with GABAergic systems, which play a key role in regulating neuronal excitability. However, it is not approved for clinical or therapeutic use in humans and remains limited to laboratory and analytical applications. Its use is highly regulated due to potential misuse and lack of established safety data.